Discover 1,917 paid clinical trials in Arlington, Texas. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
Filter
2
Filter results
Results: 1,917
Phase III, Open-label, Study of First-line Dato-DXd in Combination With Rilvegostomig for Advanced Non-squamous NSCLC With High PD-L1 Expression (TC ≥ 50%) and Without Actionable Genomic Alterations
for
Non-Small Cell Lung Cancer
Location: Fort Worth TX, Kingwood TX, Houston TX, Springdale AR,
Sponsor: AstraZeneca
Sex: All
Age: 18+
Code: NCT06357533
Phase3, Recruiting
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
for
Endometrial Cancer
Location: Fort Worth TX, Austin TX, Shreveport LA, Houston TX,
Sponsor: AstraZeneca
Sex: Female
Age: 18+
Code: NCT06989112
Phase3, Recruiting
Symbiotic-GI-16: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Gastroesophageal Cancer
for
Untreated Advanced or Metastatic Gastric, Gastroesophageal Junction , or Esophageal Adenocarcinoma,
Location: Irving TX, Pueblo CO, Colorado Springs CO, Lone Tree CO,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07392892
Phase2, Phase3, Recruiting
Symbiotic-Lung-20: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Different Anticancer Agents in Advanced Cancers
for
Advanced/Metastatic Non-Small Cell Lung Cancer,
Location: Irving TX, Garland TX, Houston TX, Sugar Land TX,
Sponsor: Pfizer
Sex: All
Age: 18+
Code: NCT07227298
Phase1, Phase2, Recruiting
Strength Training Augmenting Rehabilitation
for
Muscle Disuse Atrophy
Location: Fort Worth TX
Sponsor: Texas Christian University
Sex: All
Age: 18 - 35
Code: NCT05097092
Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
Community Opioid Innovation Network (JCOIN): TCU Clinical Research Center
for
Addiction, Opioid
Location: Fort Worth TX
Sponsor: Texas Christian University
Sex: All
Age: 18+
Code: NCT04276792
Recruiting
Translaryngeal Vibration for Hyperfunctional Voice Disorders
for
Dysphonia, Muscle Tension Dysphonia
Location: Fort Worth TX
Sponsor: Texas Christian University
Sex: All
Age: 18+
Code: NCT07145086
Phase3, Recruiting
Study of ALTO-300 in MDD
for
Major Depressive Disorder
Location: Fort Worth TX, Oklahoma City OK, Richmond TX, Rogers AR,
Sponsor: Alto Neuroscience
Sex: All
Age: 18 - 70
Code: NCT05922878
Phase2, Recruiting
Telescope Exchange Study
for
Age-related Macular Degeneration
Location: Fort Worth TX, Springfield MO, Memphis TN,
Sponsor: VisionCare, Inc.
Sex: All
Age: 65+
Code: NCT03011554
Recruiting
PRECISION Pain Research Registry
for
Chronic Low Back Pain
Location: Fort Worth TX
Sponsor: University of North Texas Health Science Center
Sex: All
Age: 21 - 70+
Code: NCT04853732
Recruiting
SHE Tribe: An Intervention to Improve Health Behavior Among Women in Underserved Communities
for
Health Promotion
Location: Fort Worth TX
Sponsor: University of North Texas Health Science Center
Sex: Female
Age: 18+
Code: NCT03463213
Recruiting
Targeting Endoplasmic Reticulum Stress in Human Hypertension
for
Hypertension
Location: Fort Worth TX
Sponsor: University of North Texas Health Science Center
Sex: All
Age: 18 - 70+
Code: NCT06025630
Phase1, Phase2, Recruiting
IHT for Mild Cognitive Impairment
for
Mild Cognitive Impairment, Memory Impairment
Location: Fort Worth TX
Sponsor: University of North Texas Health Science Center
Sex: All
Age: 55 - 70+
Code: NCT05495087
Recruiting
PARCA (a Digital Tool) to Improve Justice and Health
for
Behavioral Addiction
Location: Dallas TX, Austin TX
Sponsor: George Mason University
Sex: All
Age: 18+
Code: NCT07199374
Recruiting
A Study to Assess the Efficacy, Safety, and Tolerability of IMVT-1402 as Treatment for Adult Participants With Graves' Disease
for
Graves' Disease
Location: Dallas TX, Mesquite TX, Round Rock TX, Austin TX,
Sponsor: Immunovant Sciences GmbH
Sex: All
Age: 18 - 70+
Code: NCT06727604
Phase2, Recruiting
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations